Archives of General Internal Medicine

Reach Us +1 (202) 780-3397

Rapid Communication - Archives of General Internal Medicine (2025) Volume 9, Issue 2

Contemporary respiratory health: Challenges and advancements

Fatima Al-Zahrani*

Department of Pulmonology, King Saud University, Riyadh, Saudi Arabia

*Corresponding Author:
Fatima Al-Zahrani
Department of Pulmonology
King Saud University, Riyadh, Saudi Arabia.
E-mail: fatima.alzahrani@ksu.edu.sa

Received : 01-Apr-2025, Manuscript No. aaagim-287; Editor assigned : 03-Apr-2025, PreQC No. aaagim-287(PQ); Reviewed : 23-Apr-2025, QC No aaagim-287; Revised : 02-May-2025, Manuscript No. aaagim-287(R); Published : 13-May-2025 , DOI : 10.35841/aaagim-9.2.287

Citation: Al-Zahrani F. Contemporary respiratory health: Challenges and advancements. aaagim. 2025;09(02):287.

Visit for more related articles at Archives of General Internal Medicine

Introduction

This study provides a comprehensive overview of the global burden of chronic respiratory diseases, highlighting trends in prevalence, mortality, and disability-adjusted life-years. It emphasizes the significant public health challenge these conditions pose worldwide, offering critical data for policy-making and resource allocation in respiratory health[1].

This article reviews the current diagnostic approaches and management strategies for pediatric asthma, focusing on personalized medicine, biologics, environmental factors. It offers clinicians updated insights into improving outcomes for children with this common chronic respiratory condition[2].

This review details the latest evidence-based approaches to managing exacerbations of chronic obstructive pulmonary disease (COPD), covering pharmacologic interventions, non-pharmacologic strategies, and preventive measures. It aims to guide clinicians in reducing morbidity and mortality associated with these critical events[3].

This clinical review explores the current understanding of idiopathic pulmonary fibrosis (IPF), including its pathogenesis, diagnostic criteria, and available therapeutic options. It highlights the progressive nature of the disease and the importance of early diagnosis and intervention to improve patient outcomes[4].

This article comprehensively examines the respiratory manifestations of COVID-19, from acute presentation and diagnostic challenges to the persistent long-term sequelae. It addresses the diverse range of pulmonary complications and their impact on patient recovery and quality of life[5].

This review discusses the current guidelines for lung cancer screening using low-dose computed tomography (LDCT) and explores emerging technologies aimed at improving screening efficacy and reducing false positives. It emphasizes the importance of shared decision-making and risk stratification in screening programs[6].

This article highlights significant therapeutic advances in cystic fibrosis, particularly the development of CFTR modulator therapies, which have revolutionized treatment and improved patient prognosis. It covers the mechanisms of these new drugs and their impact on clinical outcomes[7].

This review offers an up-to-date perspective on obstructive sleep apnea, discussing its pathophysiology, diagnosis, and various treatment modalities, including lifestyle interventions, CPAP, and surgical options. It also explores future research directions in personalized medicine for this common disorder[8].

This article provides a comprehensive overview of interstitial lung diseases (ILDs), detailing their classification, diagnostic challenges, and evolving therapeutic landscape. It highlights the importance of multidisciplinary team approaches for accurate diagnosis and management, including novel antifibrotic agents[9].

This review covers recent advancements in the diagnosis and management of acute respiratory distress syndrome (ARDS), emphasizing personalized approaches to ventilation, fluid management, and pharmacologic interventions. It discusses strategies to improve outcomes and reduce mortality in critically ill patients[10].

 

Conclusion

This collection of studies offers a broad overview of contemporary challenges and significant advancements in respiratory health. It begins by detailing the extensive global burden of chronic respiratory diseases, providing essential data for policy-making and resource allocation. Subsequent insights address specific conditions like pediatric asthma, highlighting current diagnostic approaches and personalized management strategies including biologics. There are comprehensive reviews of managing exacerbations of chronic obstructive pulmonary disease, focusing on pharmacologic and non-pharmacologic interventions to reduce morbidity. For idiopathic pulmonary fibrosis, the importance of early diagnosis and intervention due to its progressive nature is underscored. The complex respiratory manifestations of COVID-19 are examined, from acute presentation to persistent long-term sequelae, exploring their impact on recovery. Lung cancer screening guidelines are discussed, emphasizing low-dose computed tomography and emerging technologies to enhance efficacy. The transformative impact of CFTR modulator therapies on cystic fibrosis management is highlighted, alongside a review of obstructive sleep apnea’s pathophysiology, diagnosis, and personalized treatment. Interstitial lung diseases are covered with an emphasis on multidisciplinary approaches and novel antifibrotic agents. Lastly, advances in the diagnosis and management of acute respiratory distress syndrome, with a focus on personalized ventilation and fluid management, are presented. These articles collectively illuminate the evolving landscape of respiratory medicine, from understanding global health challenges to implementing innovative diagnostic and therapeutic strategies across a spectrum of pulmonary conditions.

References

  1. Juan BS, Kanyin LNA, Theo EOO. Global, regional, and national burden of chronic respiratory diseases: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2023;11(1):19-35.

    2. Indexed at, Google Scholar, Crossref

  2. Michael EW, Jessica MB, Robert FLJ. Pediatric Asthma: Update on Diagnosis and Management. J Allergy Clin Immunol Pract. 2021;9(1):1-15.

    3. Indexed at, Google Scholar, Crossref

  3. Stephen IR, Antonio RA, Peter JB. Management of Exacerbations of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2022;386(12):1133-1146.

    4. Indexed at, Google Scholar, Crossref

  4. Luca R, Gisli J, Walter WN. Idiopathic pulmonary fibrosis: a clinical review. Eur Respir J. 2021;57(1):2000854.

    5. Indexed at, Google Scholar, Crossref

  5. Laura GC, Jennifer KC, Michael GO. Respiratory manifestations of COVID-19: from diagnosis to long-term sequelae. Chest. 2023;163(2):313-329.

    6. Indexed at, Google Scholar, Crossref

  6. Peter JM, Denise RA, David SG. Lung Cancer Screening: Current Recommendations and Emerging Technologies. Clin Chest Med. 2020;41(1):1-14.

    7. Indexed at, Google Scholar, Crossref

  7. Steven MR, Scott HD, Jennifer LT. Advances in the Management of Cystic Fibrosis. N Engl J Med. 2021;385(13):1218-1229.

    8. Indexed at, Google Scholar, Crossref

  8. Vikas KC, Atul M, Michael RP. Obstructive Sleep Apnea: Current Perspectives and Future Directions. Am J Respir Crit Care Med. 2020;201(9):1061-1076.

    9. Indexed at, Google Scholar, Crossref

  9. Ganesh R, Kevin KB, Jonathan KNR. Interstitial lung diseases: current concepts and future directions. Lancet. 2020;395(10240):1907-1918.

    10. Indexed at, Google Scholar, Crossref

  10. Ludovica EGF, Giacomo G, Paolo P. Acute respiratory distress syndrome: advances in diagnosis and management. BMJ. 2023;380:e072703.

    11. Indexed at, Google Scholar, Crossref

Get the App